117 related articles for article (PubMed ID: 15210691)
1. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication.
Bate C; Reid S; Williams A
J Biol Chem; 2004 Aug; 279(35):36405-11. PubMed ID: 15210691
[TBL] [Abstract][Full Text] [Related]
2. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
Bate C; Salmona M; Diomede L; Williams A
J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
[TBL] [Abstract][Full Text] [Related]
3. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
Bate C; Tayebi M; Williams A
J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
[TBL] [Abstract][Full Text] [Related]
4. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
Bate C; Nolan W; Williams A
J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
[TBL] [Abstract][Full Text] [Related]
5. The role of platelet activating factor in prion and amyloid-beta neurotoxicity.
Bate C; Salmona M; Williams A
Neuroreport; 2004 Mar; 15(3):509-13. PubMed ID: 15094513
[TBL] [Abstract][Full Text] [Related]
6. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
Bate C; Williams A
J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol esterification reduces the neurotoxicity of prions.
Bate C; Tayebi M; Williams A
Neuropharmacology; 2008 Jun; 54(8):1247-53. PubMed ID: 18448139
[TBL] [Abstract][Full Text] [Related]
9. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
[TBL] [Abstract][Full Text] [Related]
10. Role of glycosylphosphatidylinositols in the activation of phospholipase A2 and the neurotoxicity of prions.
Bate C; Williams A
J Gen Virol; 2004 Dec; 85(Pt 12):3797-3804. PubMed ID: 15557253
[TBL] [Abstract][Full Text] [Related]
11. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
[TBL] [Abstract][Full Text] [Related]
12. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
13. NMDA Receptor and L-Type Calcium Channel Modulate Prion Formation.
Zattoni M; Garrovo C; Xerxa E; Spigolon G; Fisone G; Kristensson K; Legname G
Cell Mol Neurobiol; 2021 Jan; 41(1):191-198. PubMed ID: 32239389
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phospholipase A2 increased the removal of the prion derived peptide PrP82-146 from cultured neurons.
Bate C; Ingham V; Williams A
Neuropharmacology; 2011; 60(2-3):365-72. PubMed ID: 20934441
[TBL] [Abstract][Full Text] [Related]
15. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
Bate C; Tayebi M; Williams A
BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
[TBL] [Abstract][Full Text] [Related]
16. Treatment of SMB-S15 Cells with Resveratrol Efficiently Removes the PrP(Sc) Accumulation In Vitro and Prion Infectivity In Vivo.
Wang J; Zhang BY; Zhang J; Xiao K; Chen LN; Wang H; Sun J; Shi Q; Dong XP
Mol Neurobiol; 2016 Oct; 53(8):5367-76. PubMed ID: 26440667
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
18. Stilbene Compounds Inhibit the Replications of Various Strains of Prions in the Levels of Cell Culture, PMCA, and RT-QuIC Possibly via Molecular Binding.
Zhou DH; Wang J; Xiao K; Wu YZ; Maimaitiming A; Hu C; Gao LP; Chen J; Gao C; Chen C; Shi Q; Dong XP
ACS Chem Neurosci; 2020 Jul; 11(14):2117-2128. PubMed ID: 32511904
[TBL] [Abstract][Full Text] [Related]
19. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
[TBL] [Abstract][Full Text] [Related]
20. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
